MMSI (Merit Medical Systems) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MMSI Merit Medical Systems Inc MMSI
83 GF Score
Price $71.02
GF Value $97.08
Valuation Modestly Undervalued
View Full Analysis

What is Merit Medical Systems Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

MMSI
83GF Score
Merit Medical Systems Inc MMSI
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merit Medical Systems (MMSI) Overvalued in 2026?

Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued. The current stock price of $71.02 is trading 26.8% below its estimated GF Value™ of $97.08. GuruFocus considers Merit Medical Systems to be Modestly Undervalued.

Key valuation signals for MMSI:

  • Interest Received:
  • GF Value™: $97.08 vs. price of $71.02 (26.8% below fair value)
  • GF Score™: 83/100

No single metric tells the full story. See the MMSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merit Medical Systems Business Description

Other Exchanges MM3:Germany
Address 1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
83GF Score

Get the complete analysis for MMSI

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$71.02
Price
$97.08
GF Value